Occupancy has fallen by 10% in the last five years.
- Average occupancy in the area of larger homes has fallen almost 5% between 2007 and 2006.
- The number of workers in residential growth is greater than the number of users.
- Euskoges faces the crisis by implementing management systems, quality and investment.
- "At the moment we must promote the values and services of the residence by management systems to cope with the situation," says Gabirel of Azaola manager Euskoges.
The factors are varied, but the residential sector for older people is being affected by the current economic crisis. Official data indicate a decrease in average occupancy at these sites up to 10% in the last five years. In fact, between 2007 and 2006 the average occupancy in residential and day care centers in Bizkaia fell almost 5%.
Asked about the issue of Gabirel Azaola, manager of Euskoges Group, says that the causes that have led to this situation are diverse. "We must take into account the increased offer. The number of places offered has grown over the number of seats occupied. " However, Euskoges-group they belong to the residential neighborhood and the residence Barrika Kirikiño Bilbao, has managed to maintain their occupancy levels above the industry average "through differentiation in service quality and investment."
The increase in prices in this area has also been decisive. In this sense, Gabirel Azaola points of change that has occurred in the subsidy schemes of residential places, a factor that was a slowdown in the number of requests for such places. The previous system gave support sunk after completing requirements. Now, the public is the owner of the square and provides the service upon request, generating an acknowledgment of debt for which you paid on the basis of available assets. "This led to a fall in applications for aid, especially two years ago, but has been corrected."
Even the new Act Unit assumed "some brake on the number of new users, since many people had been pending for their rights, which could receive aid, and in this sense," the new aid to informal caregivers can delay the entry in residence. "
Investing in times of crisis
Seated against the thought of "tighten their belts" when the economic situation is favorable, from a Euskoges still more focused on the forecast. "It's important to bring forward the investment and be prepared for times of crisis. In this way, the company becomes stronger and can take advantage, or at least cope with the situation in the best possible way, "says Gabirel of Azaola. Group Euskoges already invested $ 150,000 of the 300,000 expected by 2009 to improve facilities and management of their schools.
The work and commitment is reflected Euskoges with several awards: ISO 9001-2000 (Quality) in the care of older people (May 2006), ISO 14000-2004 Environment (May 2006), ISO 9001-2000 Certification the management of food in the schools themselves by Cuisine Cantabrica GASC (September 2007), Diploma Euskalit Foundation for its commitment to total quality management and excellent proven (October 2007).
The number of workers grows over the user
The data on direct care staff have been accounted for 3569 workers in residential Vizcaya, an increase of 15.31% compared to 2006. This increase is remarkable when one considers the number of users has grown by only 5.49%. For professional categories, the group with higher weight in homes, community housing and day care centers is gerocultor - assistant.
According to official figures until December 31, 2007 in Bizkaia there are 142 senior centers that offer a total of 9002 seats. These figures represent an increase over the previous year of 8.40% in number of residences and 7.98% in seats.
Bilbao meets 28% of total residential places (2,558 places), but the county with the highest number of seats is Busturia-specific Uribe with 30% (2,709 seats). In those areas where facilities are located Euskoges: Residence Kirikiño (Bilbao) and the Residence Barrika Barri.
While the total of places in residential Bizkaia increased by 7.98%, the population over 65 years grew by 1.75%. Thus, the degree of coverage of places on this population reaches 4.07% in Bizkaia. Regarding the coverage residential places (including homes, supervised community housing and apartments), the coverage is at 4.60%.
With regard to the rates in this sector, Bizkaia reach more than 2200 euros a month. For its part, the average monthly public cost for dependents at a place agreed to over 2,000 euros last year.
Sunday, February 15, 2009
Animal studies show that oil consumption slows growth of cancer.
- Research shows that the tumors before and come out are bigger and there are more animals in the affected animals taking large amounts of corn oil, unlike the animals that have taken olive oil whose tumors are benign.
- The conclusions of this work, developed by a research group at the Autonomous University of Barcelona (UAB), which coordinates the teacher Eduard Escriche, will be exhibited at the Second International Conference on Olive Oil and Health to be held in Cordoba and Jaen 20 to November 22.
The scientific evidence has shown that in vivo studies developed by the Multidisciplinary Group for the Study of Breast Cancer at UAB indicate that corn oil is a fat harmful if consumed in excess, while the oil is beneficial if drink moderately, as the coordinator of the group progresses, Eduard Escriche. The UAB team conducts its research work with a model of experimental breast cancer by studying the effects on animal consumption of two types of fats: corn oil and olive. The studies cover three approaches: the clinician, the morphological, and finally, the study of molecular mechanisms. Some investigations have revealed that the protective effect of olive oil against cancer.
"We conducted 16 experimental series and the seed oil always true. For animals who are taking large amounts of corn oil tumors before they leave, there are more animals with breast cancer, there are more number of tumors per animal, and the tumors are larger. Ie carcinogenesis is important in animals that take over corn oil, "explains Professor of Cell Biology, Physiology and Immunology. However, Escriche stresses that corn oil did not cause cancer but acts more on the promotion of this cancer, accelerating the clinical course of the disease.
What about olive oil? "Clinically, it is very clear its salutary effect: something is olive oil that despite a large amount supplied counteracts the negative effect it may have, as it is fat," she says. Fat provides energy that is the fuel needed by the tumor or cancerous cell that is why, in principle, any fat can be harmful, says the researcher. "But something is olive oil that counteracts this possible adverse effect: the specific mechanisms that we analyze the morphological and molecular studies.
Indeed, experimental studies morphological, ie, those discussed in the microscopic appearance of tumor, have revealed that the tumors originated in animals that have taken olive oil are more benign, the tumors of animals taken corn oil. A point in favor of olive oil. In addition, the teacher indicated that his research team as the other groups participating in this conference have shown that molecular data exist that support the health benefits of olive oil in relation to cancer.
To date, experiments have shown that never developed olive oil has the capacity to reverse tumor that already exists. "But we can contribute to the fight against cancer because our results indicate that slows the growth of this tumor and disease progression, although we can not classify andalusia olive oil as a drug."
All these research results will be presented at the symposium on olive oil and cancer in the II International Congress on olive oil and health to be held in Jaén and Córdoba 20 to November 22, who will moderate the Escriche, and where will know the results of research of other specialists in this field.
Olive oil for cooking
Regarding eating habits, the researchers noted that currently consume more fat than humans are of animal origin. But on the other hand, the fat oil seeds, is cheaper, is being used much in the kitchen, shifting to other types of oil like olive. " However, olive oil is kept more stable, it holds more heat and less distortion (the changes are problematic for health) to be used in cooking. That is why it is incomprehensible Eduard Escriche the current situation in the kitchens of the public: "It is a public health issue and someone should be made to understand that restaurants should not be used as the types of sunflower oils that can be harmful to health. "
But the protective effect of olive oil against cancer is also present in the crude oil for two reasons: for it contains oleic acid, a fatty acid that is behaving in a healthy manner in their interactions with cells and the components minority's exclusive extra virgin olive oil, such as antioxidants or squalene, very beneficial to many more aspects of health. Therefore, the fact administer on a regular basis could have beneficial effects.
"My recommendation would be moderate dietary consumption of fats in general by reducing animal fats and omega 6 polyunsaturated fats (the latter present in seed oils), and increasing, but within the proper amount, the olive oil and the omega 3 in fish oils and blue. Consumers should take the olive oil from an early age and acquire a healthy diet but in moderation, "advises the scientist.
- The conclusions of this work, developed by a research group at the Autonomous University of Barcelona (UAB), which coordinates the teacher Eduard Escriche, will be exhibited at the Second International Conference on Olive Oil and Health to be held in Cordoba and Jaen 20 to November 22.
The scientific evidence has shown that in vivo studies developed by the Multidisciplinary Group for the Study of Breast Cancer at UAB indicate that corn oil is a fat harmful if consumed in excess, while the oil is beneficial if drink moderately, as the coordinator of the group progresses, Eduard Escriche. The UAB team conducts its research work with a model of experimental breast cancer by studying the effects on animal consumption of two types of fats: corn oil and olive. The studies cover three approaches: the clinician, the morphological, and finally, the study of molecular mechanisms. Some investigations have revealed that the protective effect of olive oil against cancer.
"We conducted 16 experimental series and the seed oil always true. For animals who are taking large amounts of corn oil tumors before they leave, there are more animals with breast cancer, there are more number of tumors per animal, and the tumors are larger. Ie carcinogenesis is important in animals that take over corn oil, "explains Professor of Cell Biology, Physiology and Immunology. However, Escriche stresses that corn oil did not cause cancer but acts more on the promotion of this cancer, accelerating the clinical course of the disease.
What about olive oil? "Clinically, it is very clear its salutary effect: something is olive oil that despite a large amount supplied counteracts the negative effect it may have, as it is fat," she says. Fat provides energy that is the fuel needed by the tumor or cancerous cell that is why, in principle, any fat can be harmful, says the researcher. "But something is olive oil that counteracts this possible adverse effect: the specific mechanisms that we analyze the morphological and molecular studies.
Indeed, experimental studies morphological, ie, those discussed in the microscopic appearance of tumor, have revealed that the tumors originated in animals that have taken olive oil are more benign, the tumors of animals taken corn oil. A point in favor of olive oil. In addition, the teacher indicated that his research team as the other groups participating in this conference have shown that molecular data exist that support the health benefits of olive oil in relation to cancer.
To date, experiments have shown that never developed olive oil has the capacity to reverse tumor that already exists. "But we can contribute to the fight against cancer because our results indicate that slows the growth of this tumor and disease progression, although we can not classify andalusia olive oil as a drug."
All these research results will be presented at the symposium on olive oil and cancer in the II International Congress on olive oil and health to be held in Jaén and Córdoba 20 to November 22, who will moderate the Escriche, and where will know the results of research of other specialists in this field.
Olive oil for cooking
Regarding eating habits, the researchers noted that currently consume more fat than humans are of animal origin. But on the other hand, the fat oil seeds, is cheaper, is being used much in the kitchen, shifting to other types of oil like olive. " However, olive oil is kept more stable, it holds more heat and less distortion (the changes are problematic for health) to be used in cooking. That is why it is incomprehensible Eduard Escriche the current situation in the kitchens of the public: "It is a public health issue and someone should be made to understand that restaurants should not be used as the types of sunflower oils that can be harmful to health. "
But the protective effect of olive oil against cancer is also present in the crude oil for two reasons: for it contains oleic acid, a fatty acid that is behaving in a healthy manner in their interactions with cells and the components minority's exclusive extra virgin olive oil, such as antioxidants or squalene, very beneficial to many more aspects of health. Therefore, the fact administer on a regular basis could have beneficial effects.
"My recommendation would be moderate dietary consumption of fats in general by reducing animal fats and omega 6 polyunsaturated fats (the latter present in seed oils), and increasing, but within the proper amount, the olive oil and the omega 3 in fish oils and blue. Consumers should take the olive oil from an early age and acquire a healthy diet but in moderation, "advises the scientist.
Saturday, February 14, 2009
Tuberculosis and pneumonia are some key indicators of AIDS.
● The pneumologists recommend HIV testing to patients presenting with suspected diagnosis of pulmonary infections.
Given the importance of early diagnosis of HIV infection specialists SEPAR (Spanish Society of Pneumology and Thoracic Surgery) recommend the test to detect this disease prior consent to patients presenting with suspected diagnosis of tuberculosis or pneumonia of certain . Both diseases involve the diagnosis of AIDS as experienced by HIV-infected patients.
Dr. Julio Ancochea, SEPAR president, believes that "practitioners of respiratory diseases are involved in the fight against AIDS through its early warning through involving tuberculosis and pneumonia in certain possible HIV . In Spain, are currently between 120,000 and 150,000 people infected with HIV and an estimated 25% of underdiagnosing, ie ignoring patients infected with the virus. This consideration assumes great significance as a factor that increases the risk of infection.
The figures corroborate the close realción between AIDS and respiratory infections. Over 50% of AIDS-indicative diseases affecting the lungs. In Spain, according to data from the National Registry of AIDS in 2003-2007 was 8786 cases, of which 29.2% were tuberculosis, 22.7% for Pneumocystis jirovecii pneumonia (formerly Pneumocystis carinii), and 6.5% for bacterial pneumonia recurrence.
Dr. Joan Cayla, an epidemiologist and member of SEPAR provides the following figures: "In Barcelona, the 3931 cases detected from January 1994 to September 30, 2008, 32.1% were atuberculosis, 20.3% Pneumocystis jirovecii pneumonia, bacterial pneumonia 2.6% repeatability, 1.2% other mycobacterial pulmonary infections, 0.2 to bronchial or pulmonary candidiasis, 0.1% to lymphoid interstitial pneumonia, 0 , herpes simplex 1% to 0.1% and bronquial to disseminated histoplasmosis. Dr. Cayla considered, as other experts from different scientific disciplines, that "although each time there is more progress to combat the disease, the best weapon is prevention and early detection."
Recommending HIV testing to detect a respiratory illnesses mentioned, is especially relevant when further matches the high prevalence of tuberculosis in the immigrant group from certain geographic areas, a group of people who in 2007 led 20.7% of people suffering from AIDS in Spain, according to data from the National AIDS Plan. This intimate relationship between tuberculosis and AIDS reaches its maximum effect to the expectations of an increase in this figure in the coming years as 34% of newly infected HIV belongs to this group. According to official data, in 2007 there were 1345 new cases of AIDS, of whom 19.3% are immigrants.
Given the importance of early diagnosis of HIV infection specialists SEPAR (Spanish Society of Pneumology and Thoracic Surgery) recommend the test to detect this disease prior consent to patients presenting with suspected diagnosis of tuberculosis or pneumonia of certain . Both diseases involve the diagnosis of AIDS as experienced by HIV-infected patients.
Dr. Julio Ancochea, SEPAR president, believes that "practitioners of respiratory diseases are involved in the fight against AIDS through its early warning through involving tuberculosis and pneumonia in certain possible HIV . In Spain, are currently between 120,000 and 150,000 people infected with HIV and an estimated 25% of underdiagnosing, ie ignoring patients infected with the virus. This consideration assumes great significance as a factor that increases the risk of infection.
The figures corroborate the close realción between AIDS and respiratory infections. Over 50% of AIDS-indicative diseases affecting the lungs. In Spain, according to data from the National Registry of AIDS in 2003-2007 was 8786 cases, of which 29.2% were tuberculosis, 22.7% for Pneumocystis jirovecii pneumonia (formerly Pneumocystis carinii), and 6.5% for bacterial pneumonia recurrence.
Dr. Joan Cayla, an epidemiologist and member of SEPAR provides the following figures: "In Barcelona, the 3931 cases detected from January 1994 to September 30, 2008, 32.1% were atuberculosis, 20.3% Pneumocystis jirovecii pneumonia, bacterial pneumonia 2.6% repeatability, 1.2% other mycobacterial pulmonary infections, 0.2 to bronchial or pulmonary candidiasis, 0.1% to lymphoid interstitial pneumonia, 0 , herpes simplex 1% to 0.1% and bronquial to disseminated histoplasmosis. Dr. Cayla considered, as other experts from different scientific disciplines, that "although each time there is more progress to combat the disease, the best weapon is prevention and early detection."
Recommending HIV testing to detect a respiratory illnesses mentioned, is especially relevant when further matches the high prevalence of tuberculosis in the immigrant group from certain geographic areas, a group of people who in 2007 led 20.7% of people suffering from AIDS in Spain, according to data from the National AIDS Plan. This intimate relationship between tuberculosis and AIDS reaches its maximum effect to the expectations of an increase in this figure in the coming years as 34% of newly infected HIV belongs to this group. According to official data, in 2007 there were 1345 new cases of AIDS, of whom 19.3% are immigrants.
Spanish urologists continue European recommendations for diagnosis and treatment of benign prostatic hyperplasia.
• According to survey, with 388 urologists from all regions, both at the hospital as an outpatient, and public and private.
• Spain is an international reference in Urology, for their high scientific level and action in daily clinical practice.
• The firm has received the second prize for Best Oral Communication in the X International Congress of the Iberoamerican Society of Urogynecology and Neurourología (SINUG).
Spanish urologists showed almost unanimous agreement with the recommendations established for their specialty throughout Europe regarding the diagnosis and treatment of benign prostatic hyperplasia (BPH). So reveals a study that involved 388 urologists from all over Spain, and has received the second prize for best Poster / Oral Communication at the X International Congress of the Iberoamerican Society of Urogynecology and Neurourología (SINUG) held in Portugal last October.
The objective of this research, says Dr. Andres de Palacio, principal investigator of the study and clinical chief of the Urology Department of the Hospital San Rafael de Madrid, was "to assess the diagnosis and treatment performed by urologists Spanish patients with BPH in their daily practice "and" measure the degree of agreement with the recommendations on the management of these patients, which were made in 2006 by the European Association of Urology (EAU-short).
For the study, which has enjoyed the patronage of Astellas Pharma and entitled "Therapeutic and diagnostic approach in routine clinical practice for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS / BPH) Queries Urology "We surveyed 388 urologists from all regions, both at the hospital as an outpatient, and public and private.
Among the findings, highlights the fact that most specialists followed the recommendations of the UAE, which allows professionals to "unify" and "constantly updated on the various pathologies, to give the patient the best approaches diagnosis and therapy, both pharmacological and surgical, such as laser, "specifies Andrés Palacio.
The doctor says, well, that Spain has been "referring to the European and global urology with a high-level scientific and action in daily clinical practice, not only in the HBP, but in all the pathologies covering the specialty. " This is demonstrated by the Spanish participation in the expert committee that drafted the recommendations in 2006.
Pharmacological treatment of BPH
Regarding the drug most frequently chosen by urologists as a first option, the study shows that monotherapy, one in 55.2% of the cases, the drug combination in 19.4% of the time. "The single is the use of herbal medicine alone, alpha-blockers or inhibitors of 5 alpha-reductase, whereas the combination therapy, involves the administration of an alpha-blocker and an inhibitor of 5 alpha-reductase," explains Dr. Palacio.
Within combination therapy, the research reveals that 77.3% of physicians recognized the combination of alpha-blockers and inhibitors of 5 alpha-reductase as the most common. Dr. Andres de Palacio argues that this election is that "it is very beneficial for patients because they receive prompt and sustained resolution of symptoms caused by alpha-blockers and long-term benefits of treatment with inhibitors of 5 alpha-reductase.
Likewise, a 97.2% of physicians considered the study of alpha-blockers as an effective therapy for BPH, "because it produces a more rapid improvement of symptoms and urinary flow rate." Among the alpha-blockers, Dr. de Palacio stressed the effectiveness of tamsulosin, a drug of last generation and is characterized by a very rapid and sustained relief in time of prostatic symptoms. For the specialist, now is the one with less incidence of cardiovascular side effects. "
Finally, in relation to diagnostic procedures, between 96% and 100% of urologists surveyed agreed that the most frequent are the history, physical examination, determination of prostate specific antigen (PSA) and touch rectum. At the other extreme, only 36% said their agreement with the recommendation of using voiding diary, a document completed by the patient which contains the number of voids and volume of urine at each micturition.
• Spain is an international reference in Urology, for their high scientific level and action in daily clinical practice.
• The firm has received the second prize for Best Oral Communication in the X International Congress of the Iberoamerican Society of Urogynecology and Neurourología (SINUG).
Spanish urologists showed almost unanimous agreement with the recommendations established for their specialty throughout Europe regarding the diagnosis and treatment of benign prostatic hyperplasia (BPH). So reveals a study that involved 388 urologists from all over Spain, and has received the second prize for best Poster / Oral Communication at the X International Congress of the Iberoamerican Society of Urogynecology and Neurourología (SINUG) held in Portugal last October.
The objective of this research, says Dr. Andres de Palacio, principal investigator of the study and clinical chief of the Urology Department of the Hospital San Rafael de Madrid, was "to assess the diagnosis and treatment performed by urologists Spanish patients with BPH in their daily practice "and" measure the degree of agreement with the recommendations on the management of these patients, which were made in 2006 by the European Association of Urology (EAU-short).
For the study, which has enjoyed the patronage of Astellas Pharma and entitled "Therapeutic and diagnostic approach in routine clinical practice for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS / BPH) Queries Urology "We surveyed 388 urologists from all regions, both at the hospital as an outpatient, and public and private.
Among the findings, highlights the fact that most specialists followed the recommendations of the UAE, which allows professionals to "unify" and "constantly updated on the various pathologies, to give the patient the best approaches diagnosis and therapy, both pharmacological and surgical, such as laser, "specifies Andrés Palacio.
The doctor says, well, that Spain has been "referring to the European and global urology with a high-level scientific and action in daily clinical practice, not only in the HBP, but in all the pathologies covering the specialty. " This is demonstrated by the Spanish participation in the expert committee that drafted the recommendations in 2006.
Pharmacological treatment of BPH
Regarding the drug most frequently chosen by urologists as a first option, the study shows that monotherapy, one in 55.2% of the cases, the drug combination in 19.4% of the time. "The single is the use of herbal medicine alone, alpha-blockers or inhibitors of 5 alpha-reductase, whereas the combination therapy, involves the administration of an alpha-blocker and an inhibitor of 5 alpha-reductase," explains Dr. Palacio.
Within combination therapy, the research reveals that 77.3% of physicians recognized the combination of alpha-blockers and inhibitors of 5 alpha-reductase as the most common. Dr. Andres de Palacio argues that this election is that "it is very beneficial for patients because they receive prompt and sustained resolution of symptoms caused by alpha-blockers and long-term benefits of treatment with inhibitors of 5 alpha-reductase.
Likewise, a 97.2% of physicians considered the study of alpha-blockers as an effective therapy for BPH, "because it produces a more rapid improvement of symptoms and urinary flow rate." Among the alpha-blockers, Dr. de Palacio stressed the effectiveness of tamsulosin, a drug of last generation and is characterized by a very rapid and sustained relief in time of prostatic symptoms. For the specialist, now is the one with less incidence of cardiovascular side effects. "
Finally, in relation to diagnostic procedures, between 96% and 100% of urologists surveyed agreed that the most frequent are the history, physical examination, determination of prostate specific antigen (PSA) and touch rectum. At the other extreme, only 36% said their agreement with the recommendation of using voiding diary, a document completed by the patient which contains the number of voids and volume of urine at each micturition.
Minimally invasive surgery: Olympus enters into an exclusive agreement with Advanced Surgical Concepts.
- Minimally invasive surgery: Olympus improved credentials for entry into an exclusive sales and distribution with the market leader and technology Advanced Surgical Concepts
Olympus has strengthened its position as a leader in the field of minimally invasive surgery by signing an exclusive agreement to distribute and immediate products of the Irish company Advanced Surgical Concepts worldwide. ASC is the only global provider of operational techniques for laparoscopic ports leading through a single access point - the patient's navel. Olympus is now the exclusive distributor for the full range of products involved.
The single-site surgery laparoendoscópica (surgery LESS) - endoscopic surgery through the navel - is ranked as one of the most important recent innovations in medical technology. As a distributor of TriPorts and QuadPorts developed by ASC, Olympus is now a key player in the technology of this high potential market. Using these ports can be made three or four instruments in the patient's abdomen through a single access point (eg. The navel). So far, the most minimally invasive requiring three or four independent access points.
"As world market leader in the field of endoscopic quality systems, we can now supply ports, optical instruments and manuals for the dynamic field of minimally invasive surgery from a single source," said Heinz Jacqui, Managing Director of Olympus Winter & Ibe, referring to the strategic partnership. In addition to its responsibility in the area of cooperation of sales, this company also operates a subsidiary center development and production of surgical Olympus.
"With the cooperation with Olympus and its global distribution network we can offer our products in combination with the best current endoscopic system," said Frank Bonadies, CEO of Advanced Surgical Concepts Limited. "The synergy between the products of our companies will enable us to dominate the market for LESS surgery and results in long-term cooperation of our companies."
The market for minimally invasive products is constantly expanding. In Europe alone, there are around 900,000 gallbladder operations a year. In the coming years, a greater number of operations of the gallbladder through the umbilicus. Experts predict a significant increase in transactions, including transactions involving a full-surgery without scars within the next few years.
Besides the advantages for the patient in terms of aesthetics and reducing the pain of the healing process, this new form of access to hospital benefits, with costs at the same level as the conventional operational techniques, while the trend towards times shorter hospitalization and lower hospital costs by reducing the risk of post-operative infection.
With its products and systems solutions, Olympus is positioning as a capable partner for the medical sector. Rigid and flexible endoscopes are playing a decisive role in the diagnosis and minimally invasive therapies. The range of company products includes endoscopes and systems solutions for a wide range of internal medicine and surgery, endoscopic video systems, reprocessing systems and a wide selection of products endoterapia.
Olympus has strengthened its position as a leader in the field of minimally invasive surgery by signing an exclusive agreement to distribute and immediate products of the Irish company Advanced Surgical Concepts worldwide. ASC is the only global provider of operational techniques for laparoscopic ports leading through a single access point - the patient's navel. Olympus is now the exclusive distributor for the full range of products involved.
The single-site surgery laparoendoscópica (surgery LESS) - endoscopic surgery through the navel - is ranked as one of the most important recent innovations in medical technology. As a distributor of TriPorts and QuadPorts developed by ASC, Olympus is now a key player in the technology of this high potential market. Using these ports can be made three or four instruments in the patient's abdomen through a single access point (eg. The navel). So far, the most minimally invasive requiring three or four independent access points.
"As world market leader in the field of endoscopic quality systems, we can now supply ports, optical instruments and manuals for the dynamic field of minimally invasive surgery from a single source," said Heinz Jacqui, Managing Director of Olympus Winter & Ibe, referring to the strategic partnership. In addition to its responsibility in the area of cooperation of sales, this company also operates a subsidiary center development and production of surgical Olympus.
"With the cooperation with Olympus and its global distribution network we can offer our products in combination with the best current endoscopic system," said Frank Bonadies, CEO of Advanced Surgical Concepts Limited. "The synergy between the products of our companies will enable us to dominate the market for LESS surgery and results in long-term cooperation of our companies."
The market for minimally invasive products is constantly expanding. In Europe alone, there are around 900,000 gallbladder operations a year. In the coming years, a greater number of operations of the gallbladder through the umbilicus. Experts predict a significant increase in transactions, including transactions involving a full-surgery without scars within the next few years.
Besides the advantages for the patient in terms of aesthetics and reducing the pain of the healing process, this new form of access to hospital benefits, with costs at the same level as the conventional operational techniques, while the trend towards times shorter hospitalization and lower hospital costs by reducing the risk of post-operative infection.
With its products and systems solutions, Olympus is positioning as a capable partner for the medical sector. Rigid and flexible endoscopes are playing a decisive role in the diagnosis and minimally invasive therapies. The range of company products includes endoscopes and systems solutions for a wide range of internal medicine and surgery, endoscopic video systems, reprocessing systems and a wide selection of products endoterapia.
Vissum performed for the first time in Spain, an alternative to corneal transplantation.
- With this new technique, the recovery can be reduced from one year to one week
- It applies to 50% of patients who currently require a traditional cornea transplant
Medical teams and Dr. Gerrit Melles Vissum Ophthalmologic Corporation, led by Dr. Jorge Alió, have, this morning, three endothelial transplant surgery with an innovative technique in the world. The interventions have been conducted at the invitation of Vissum, Dr. Gerrit Melles, corneal surgeon and director of the Netherlands Institute for Innovative Ocular Surgery, Rotterdam, the creator of this procedure and the eye bank of the technology necessary to perform this operation.
Dr Alió Dr Melles-right-left-for-intervention
This surgical technique, called Endothelial keratoplasty of the Descemet membrane (DMEK for short), is the transplantation of the endothelial membrane, which represents a revolution in these operations because it is not complete cornea transplant or his back, as at present.
Approximately half of corneal transplants are currently performed on patients who have suffered an endothelial failure, mainly due to a previous operation that, by its complications, has led to its destruction, either by trauma or endothelial dystrophy . Ultimately, this technique is applicable to half the cases of corneal transplantation, thus avoiding a much longer post, and getting the patient to have a better view. Plus, everything is done in a much more controlled environment, with a more secure technique.
Cornea with slider
In this sense, the post is fast, the patient after surgery, remains in the clinic two hours and then has to keep one or two days to rest in his home. It then conducts a review to verify that the transplanted layer was seated correctly.
According to Prof. Jorge Alió, Vissum medical director, "the difference is important because, until now, we are dealing with disease, although only the diseased endothelial layer, is the transplanting corneal tissue healthy. That means that transplants are a greater amount of tissue that interferes with the passage of light, recovering a little vision. "
However, with the technical DMEK was transplanted the single layer of tissue that is sick, so the surgery is more functional as there is no residual stromal tissue. The consequence is important: the patient recovers much more quickly and completely. Thus, a corneal transplant has a normal rehabilitation period for a year, while this technique is limited to rehabilitation for a week or two at most, "says Prof. Alió.
Another advantage worth noting is that the eyes cornea donors remain full, so that it can be used on another patient. Moreover, in the case of a rejection, which occurs in 18% of cases, the only thing replaced is the tissue where the endothelium. It is, says Dr. Jorge Alió, "a revolution because it can be transplanted for the first time the endothelial layer, which is a single-cell layer of cells that do not play along with the support they have is called basal membrane or Descemet membrane.
This is not an operation that requires a high-tech, but it requires a sophisticated technique of cultivation of donor tissue to be properly prepared, which requires it to be sent from the eye bank in Rotterdam.
This is the first time that the intervention with this innovative surgical procedure is performed outside of Holland. "None other than Dr. Melles has been able to develop this technology to take off the Descemet membrane and take it to the recipient eye," says Dr. Alió. The Dutch ophthalmologist and has operated at approximately one hundred patients in his country, but from today will be implemented in Spain through the Corporation Oftalmológica Vissum.
About VISSUM
Ophthalmologic VISSUM Corporation was founded in 2004 as a result of the union of six of the most prestigious in our country ophthalmologic centers. Is composed of the best medical, paramedical and research, with the most advanced technology to treat all of the different ocular pathologies: Pediatric Ophthalmology, Refractive Laser Surgery, cataracts or retinal disorders, among others.
Corporation Ophthalmologic VISSUM Centers is comprised of over 300 professionals, led by Prof. Dr. Jorge L. Alió, Professor of Ophthalmology, University Miguel Hernández. Most of these centers are certified to ISO-9001 and some of them even with the Joint Commission of the United States, such as Ophthalmological Institute of Alicante. Also, involved in numerous research projects in collaboration with the University Miguel Hernández (Elche) and the University of Alcalá (Madrid), among others.
Ophthalmologic VISSUM Corporation currently has more than 35 clinical centers specialized in Ophthalmology, located in eleven provinces, Alicante, Albacete, Murcia, Almeria, Gran Canaria, Madrid, Sevilla, Cádiz, Guadalajara, Segovia and Zaragoza in 2007 and has closed exercise with a turnover of 32.2 billion euros.
- It applies to 50% of patients who currently require a traditional cornea transplant
Medical teams and Dr. Gerrit Melles Vissum Ophthalmologic Corporation, led by Dr. Jorge Alió, have, this morning, three endothelial transplant surgery with an innovative technique in the world. The interventions have been conducted at the invitation of Vissum, Dr. Gerrit Melles, corneal surgeon and director of the Netherlands Institute for Innovative Ocular Surgery, Rotterdam, the creator of this procedure and the eye bank of the technology necessary to perform this operation.
Dr Alió Dr Melles-right-left-for-intervention
This surgical technique, called Endothelial keratoplasty of the Descemet membrane (DMEK for short), is the transplantation of the endothelial membrane, which represents a revolution in these operations because it is not complete cornea transplant or his back, as at present.
Approximately half of corneal transplants are currently performed on patients who have suffered an endothelial failure, mainly due to a previous operation that, by its complications, has led to its destruction, either by trauma or endothelial dystrophy . Ultimately, this technique is applicable to half the cases of corneal transplantation, thus avoiding a much longer post, and getting the patient to have a better view. Plus, everything is done in a much more controlled environment, with a more secure technique.
Cornea with slider
In this sense, the post is fast, the patient after surgery, remains in the clinic two hours and then has to keep one or two days to rest in his home. It then conducts a review to verify that the transplanted layer was seated correctly.
According to Prof. Jorge Alió, Vissum medical director, "the difference is important because, until now, we are dealing with disease, although only the diseased endothelial layer, is the transplanting corneal tissue healthy. That means that transplants are a greater amount of tissue that interferes with the passage of light, recovering a little vision. "
However, with the technical DMEK was transplanted the single layer of tissue that is sick, so the surgery is more functional as there is no residual stromal tissue. The consequence is important: the patient recovers much more quickly and completely. Thus, a corneal transplant has a normal rehabilitation period for a year, while this technique is limited to rehabilitation for a week or two at most, "says Prof. Alió.
Another advantage worth noting is that the eyes cornea donors remain full, so that it can be used on another patient. Moreover, in the case of a rejection, which occurs in 18% of cases, the only thing replaced is the tissue where the endothelium. It is, says Dr. Jorge Alió, "a revolution because it can be transplanted for the first time the endothelial layer, which is a single-cell layer of cells that do not play along with the support they have is called basal membrane or Descemet membrane.
This is not an operation that requires a high-tech, but it requires a sophisticated technique of cultivation of donor tissue to be properly prepared, which requires it to be sent from the eye bank in Rotterdam.
This is the first time that the intervention with this innovative surgical procedure is performed outside of Holland. "None other than Dr. Melles has been able to develop this technology to take off the Descemet membrane and take it to the recipient eye," says Dr. Alió. The Dutch ophthalmologist and has operated at approximately one hundred patients in his country, but from today will be implemented in Spain through the Corporation Oftalmológica Vissum.
About VISSUM
Ophthalmologic VISSUM Corporation was founded in 2004 as a result of the union of six of the most prestigious in our country ophthalmologic centers. Is composed of the best medical, paramedical and research, with the most advanced technology to treat all of the different ocular pathologies: Pediatric Ophthalmology, Refractive Laser Surgery, cataracts or retinal disorders, among others.
Corporation Ophthalmologic VISSUM Centers is comprised of over 300 professionals, led by Prof. Dr. Jorge L. Alió, Professor of Ophthalmology, University Miguel Hernández. Most of these centers are certified to ISO-9001 and some of them even with the Joint Commission of the United States, such as Ophthalmological Institute of Alicante. Also, involved in numerous research projects in collaboration with the University Miguel Hernández (Elche) and the University of Alcalá (Madrid), among others.
Ophthalmologic VISSUM Corporation currently has more than 35 clinical centers specialized in Ophthalmology, located in eleven provinces, Alicante, Albacete, Murcia, Almeria, Gran Canaria, Madrid, Sevilla, Cádiz, Guadalajara, Segovia and Zaragoza in 2007 and has closed exercise with a turnover of 32.2 billion euros.
The Senate supports the project by Cinta Solidary Disability.
- The Senators will get the tape in the chamber several
Next Tuesday December 16, at 1600 hours, coinciding with the start of the plenary session, the senators will receive in his place by the tape Solidary Disability.
Senate President Javier Rojo, Mario Garcia to receive Sánchez, president of the Spanish Confederation of People with Disabilities and Physical Organic (COCEMFE) and Francisco Miguel Alonso Garcia, president of the Center for Special Use GPS, the project promoter. Ribbon Solidarity initiative's main objective is to obtain economic resources to finance projects related to the integration of persons with disabilities.
The Senate has joined the initiative as "Ambassador of solidarity honor" by supporting a project to improve the quality of life for people with disabilities, a group that includes more than 3,500,000 people in Spain. Improving the working conditions of persons with disabilities through enhanced training activities, an increased sensitivity of the business and investment in accessibility improvements.
Ribbon Solidarity on the project involved some of the most important designers of the national scene, who have selflessly contributed to the design of a ribbon or lanyard to your mobile personal stamp. The tape is available in the shops attached to the project and the benefits iran for social integration and employment of persons with disabilities.
COCEMFE, Spanish Confederation of People with Disabilities and Physical Organic, is a non-governmental non-profit was formed in 1980. Its aim is unite, strengthen, train and coordinate the efforts and activities of the organizations working on behalf of people with physical and functional to defend their rights and improve their quality of life.
The body brings together more than 1,500 organizations are divided into autonomous confederations, national and provincial federations, which in turn, bring together the various local associations.
Subscribe to:
Posts (Atom)
